- JP-listed companies
- Ina Research Inc.
- Cash flow
Ina Research Inc. (E20922) Cash flow
Market cap
P/E ratio
Inari Research provides contract testing services to help pharmaceutical companies evaluate drug safety and effectiveness using GLP-compliant laboratory facilities.
| 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | |
| Depreciation & amortization | 246 | 215 | 207 | 182 | 123 | 102 | 104 | 112 | 142 | 159 |
| Cash from operations | 13 | 209 | 125 | -171 | -2 | 644 | -93 | 271 | 439 | 690 |
| Capital expenditures | -46 | -50 | -42 | -47 | -24 | -17 | -29 | -47 | -143 | -61 |
| Cash from investing | 132 | 14 | -42 | -30 | 7 | 22 | -37 | -39 | -168 | -82 |
| Payments for dividends | -24 | -9 | -18 | -9 | -0 | -0 | - | - | - | - |
| Proceeds from issuance of term debt, net | 400 | 400 | 80 | 400 | - | - | 253 | - | 100 | - |
| Repayments of term debt | -395 | -325 | -335 | -138 | -11 | - | -172 | -100 | -115 | -120 |
| Cash from financing | -169 | -88 | -7 | -132 | 88 | 13 | -366 | -150 | -79 | -292 |